Salute e Benessere

Study Confirms that Frequency of Source Plasma Donation as Regulated by U.S. FDA…

This PPTA-sponsored research was designed to assess the impact of U.S. donation frequency on donor self-reported health and well-being. It involved 5,608 donors from 14 U.S. donation centers, who were enrolled in a cross-sectional study to assess self-reported health-related quality of life (HRQoL) and well-being. Donors were divided by sex and assigned to four different groups, based on the frequency of their donations during the 12 months prior to enrollment in the study. This…
PR Newswire
25/08/2023

Groupe Casino: Update on the grace periods (délais de grâce) relating to the…

Update on the grace periods ( délais de grâce ) relating to the notes issued by the Casino group Paris, 25 August 2023As an update to its noteholders, the Casino group indicates that the President of the Paris Commercial Court ( Président du tribunal de commerce de Paris ) will rule in September on requests for grace periods ( délais de grâce ) relating to (i) the senior unsecured notes issued by Casino, due 2026 and 2027, (ii) the EMTN notes due 2026 1, and (iii) the...
Nasdaq GlobeNewswire
25/08/2023

Progress share buy-back program Fagron

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 25 August 2023 – 6PM CET Progress share buy-back program Fagron In the period from 21 August 2023 through 25 August 2023, Fagron purchased 29,600 of its owns shares at an average price of €16.04 per share corresponding to a total amount of €474,875.16. These purchases are part of the share buy-back program of up to 138,372 Fagron shares to fulfill Fagron's obligations under its long term incentive scheme, which was...
Nasdaq GlobeNewswire
25/08/2023

Transactions in Zealand Pharma shares and/or related securities by persons…

Company announcement – No. 30 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, August 25, 2023–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or...
Nasdaq GlobeNewswire
25/08/2023

Major shareholder announcement

Company announcement no. 44 - 2325 August 2023 Major shareholder announcementPursuant to Section 30 of the Danish Capital Markets Act, NTG Nordic Transport Group A/S (“NTG”) hereby announces receipt of the following notification pursuant to Section 38 of the Danish Capital Markets Act and Section 55 of the Danish Companies Act. H5 Capital A/SPursuant to the Danish Capital Markets Act Section 38 and the Danish Companies Act Section 55, H5 Capital A/S (CVR no. 37454893) hereby...
Nasdaq GlobeNewswire
25/08/2023

Reporting of transactions made by persons discharging managerial…

Company announcement no. 43 - 23 25 August 2023 Reporting of transactions made by persons discharging managerial responsibilities, and persons closely associated with them, in NTG's shares In accordance with section 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation), NTG Nordic Transport Group A/S (“NTG”), CVR no. 12546106, hereby announces receipt of the following notification from persons...
Nasdaq GlobeNewswire
25/08/2023

Trading by management and close relations of management

Please read the full announcement in PDF Attachment 2023_56_Trading_by_management
Nasdaq GlobeNewswire
25/08/2023

PCI Biotech: Invitation to first half interim 2023 results presentation

Oslo, Norway, 25 August 2023 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2023 interim report on Thursday 31 August 2023, 08:30am – 09:30am CEST (local time). The presentation will be held as a live webcast and can be accessed through www.pcibiotech.com. There will be a Q&A session at the end of the presentation and it will be possible to post written questions through the webcast console.The company will be represented by Ronny Skuggedal...
Nasdaq GlobeNewswire
25/08/2023

Reporting of transactions made by persons discharging managerial…

Company announcement no. 42 - 23 25 August 2023 Reporting of transactions made by persons discharging managerial responsibilities, and persons closely associated with them, in NTG's shares In accordance with section 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation), NTG Nordic Transport Group A/S (“NTG”), CVR no. 12546106, hereby announces receipt of the following notification from persons...
Nasdaq GlobeNewswire
25/08/2023

Tigermed Reports 2023 Interim Results

Business Highlight: Business Highlight: Tigermed maintained its strong position in the CRO industry in the first half of 2023 by providing comprehensive services and empowering global biopharmaceutical innovation with high quality and commitment. As ofJune 30, 2023, Tigermed had 772 ongoing drug clinical research projects, including over 40 ongoing clinical trials inthe United States, 35 ongoing clinical trial projects in the EMEA ( Europe,Middle East,Africa ) region, and 31...
PR Newswire
25/08/2023

Zhiyi Biotech Announced First Subject Dosed in the U.S. Phase 1 clinical Trial…

SK10, the first Bacteroides fragilis-based live biotherapeutic product (LBP) obtained FDA IND approval, is also the first LBP of Next-generation probiotics developed by Chinese biotech company that approved for clinical trials by FDA. It was the world's first application of LBPs for Chemotherapy-induced Diarrhea (CID). SK10, the firstBacteroides fragilis -based live biotherapeutic product (LBP) obtained FDA IND approval, is also the first LBP of Next-generation probiotics developed by Chinese...
PR Newswire
25/08/2023

XCMG Machinery Supports Africa's Infrastructure Development with Diverse…

XCMG's high-quality products and reliable services have safeguarded the smooth construction progress of the Dangote Refinery. During construction, the average runtime of a single XCMG excavator was more than 8,000 hours. To cope with the harsh environment as Lagos, a city by the sea, has high temperatures, humidity, and dust, which pose great challenges to the adaptability and reliability of construction machinery equipment, XCMG made customized upgrades and improvements to ensure optimum…
PR Newswire
25/08/2023

Infant Bacterial Therapeutics AB (publ) Interim report January 1 - June 30…

Message from the CEO Our Phase-III study, the largest of its kind ever conducted, is progressing across 88 hospitals in ten countries. We have now recruited 85% of the patients (1824 out of the planned 2158), and with the current rate of approximately 75 patients per month, we anticipate completing the recruitment by the end of the year.In June, the Data Monitoring Committee (DMC) concluded its scheduled safety analysis of data from the first 1400 recruited patients. The DMC's conclusion...
Nasdaq GlobeNewswire
25/08/2023

BBS-Bioactive Bone Substitutes Plc: Half-Year Financial Report 1 Jan - 30 Jun…

BBS-Bioactive Bone Substitutes Plc, Half-Year Financial Report, 25 August 2023 at 09.00 (EET) This is a summary of BBS-Bioactive Bone Substitutes Plc's Half-Year Financial Report for January– June 2023 . The entire report is attached to this Company Announcement as a pdf file. The report is also available on BBS-Bioactive Bone Substitutes Plc's website athttps://www.bbs-artebone.fi/. BBS-Bioactive Bone Substitutes Plc: Half-Year Financial Report 1 Jan - 30 Jun 2023...
Nasdaq GlobeNewswire
25/08/2023

Sandoz receives FDA approval for Tyruko® (natalizumab-sztn), first and only…

Biosimilar Tyruko ® approved for allindications of reference medicine, with same dosing and administration scheduleSandoz continues to expand access to much-needed medications for patients in US, offering another treatment option to help control relapsing forms of multiple sclerosisUS FDA approval based on robust Phase I and Phase III clinical studies; each met primary endpoints and showed Tyruko provides same risks and benefits in terms of efficacy, safety and...
Nasdaq GlobeNewswire
25/08/2023

Peripheral Artery Disease Global Market to Surpass USD 54 Billion Mark by 2027 |…

Key Takeaways from the Peripheral Artery Disease Market Report Key Takeaways from the Peripheral Artery Disease Market Report To read more about the latest highlights related to the peripheral artery disease market, get a snapshot of the key highlights entailed in theGlobal Peripheral Artery Disease Market Report Peripheral Artery Disease Overview Peripheral Artery Disease (PAD) is a prevalent circulatory condition that affects the arteries carrying blood away from the heart...
PR Newswire
24/08/2023

Jazz Pharmaceuticals to Participate in Citi's 18th Annual BioPharma Conference

About Jazz PharmaceuticalsJazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic…
PR Newswire
24/08/2023

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of…

Company announcement – No. 29 / 2023 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, August 24, 2023–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 15,834 divided into 15,834 new shares with a nominal value of DKK 1...
Nasdaq GlobeNewswire
24/08/2023

Medical Equipment Industry Outlook - Expansion to be Propelled by Elevated Costs…

Gain more insights into the medical equipment industry trends with a free consultation: Gain more insights into the medical equipment industry trends with a free consultation: https://bit.ly/40IIkfq The Global Market Model also offers insights on the following key industry indicators to spot key medical equipment industry trends – Leverage the capabilities of the Global Market Model to spot opportunities in medical device industry. We're here to address your specific requirements...
PR Newswire
24/08/2023

The Automated Liquid Handling Systems Market is anticipated to grow at a CAGR of…

Automated liquid handling systems offer multiple benefits, including reduced risk of contamination, enhanced precision, and high throughput across clinical research. By automating routine liquid handling procedures, these advanced systems empower researchers to redirect their focus towards intricate tasks, fostering innovation and accelerating scientific discoveries. Recognizing the demand for tailored solutions, industry leaders are actively engaged in the development of user-friendly…
PR Newswire
24/08/2023

Major shareholder announcement - BlackRock, Inc.

ANNOUNCEMENT NO. 24024 August 2023Major shareholder announcementMajor shareholder announcement–BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that BlackRock, Inc. on August 22, 2023, has increased its holding of shares in ChemoMetec A/S to 5.06% of the share capital and voting rights, and that the shareholding thus exceeds the 5 per cent limit in section 38 of the...
Nasdaq GlobeNewswire
24/08/2023

Ping An Health announces 2023 interim results

Corporate health management market sets benchmark, demonstrates significant synergy in integrated finance + healthcare Corporate health management market sets benchmark, demonstrates significant synergy in integrated finance + healthcare Drawing upon core competitive advantages including a comprehensive supplier network, leading services, extensive payer resources and strong eco-system empowerment, Ping An Health has further deepened its exploration and implementation of the managed care…
PR Newswire
24/08/2023

Canton Fair Unlocks New Experiences with Latest Smart Home Appliances

Mamibot Manufacturing (Shanghai) Co., Ltd., a global leader in the development and production of home service robots, and a renowned name in the European robotics field, is showcasing its latest innovation at the Canton Fair. Its flagship Robot Lawn Mower, is equipped with advanced infrared, rain, pressure, and tilt sensors. This intelligent device can plan cutting paths, avoid obstacles, climb easily, and monitor the external environment. For more information, visit the Mamibot Canton Fair page…
PR Newswire
24/08/2023

Fruit Street Health, Limited joins prestigious DigitalHealth.London Accelerator…

Now in its seventh consecutive year, the DigitalHealth.London Accelerator programme is delivered by the Health Innovation Network (HIN), the Academic Health Science Network (AHSN) for South London. It is funded by DigitalHealth.London and the HIN's partners, such as the Office for Life Sciences and CW+. £185k has also been granted from the UK Government via the UK Shared Prosperity Fund to fund some aspects of this programme. Now in its seventh consecutive year, the DigitalHealth.London...
PR Newswire
24/08/2023
Altri  Comunicati